Evidence map›Paper›PMID 39286346›Full record

ArticleFrontiers in microbiology2024

Antimicrobial and antibiofilm effects of cyclic dipeptide-rich fraction from

Farid Shirmardi Dezaki, Tahmineh Narimani, Mustafa Ghanadian, Elham Bidram, Farkhondeh Poursina

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in molecular biosciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farid Shirmardi DezakiDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Tahmineh NarimaniDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mustafa GhanadianIsfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Elham BidramBiosensor Research Center (BRC), Department of Biomaterials, Nanotechnology, and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences (IUMS), Isfahan, Iran.
Farkhondeh PoursinaDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: One effective method to combat bacterial infections is by using bacteria itself as a weapon. Methods: In this study, the CDP fraction was isolated from the supernatant of Results and discussion: According to the study, the minimum inhibitory concentration (MIC) of the desired compound was found to be 1.25 mg/mL against Conclusion: In general, we found that GO NSs possess antimicrobial properties and enhance cyclodipeptides' activity against

Indexed as

Acinetobacter baumanniiantibiofilmantimicrobialcyclodipeptidegraphene oxidenanosheetsStaphylococcus aureus

Identifiers

PMID39286346
PMCPMC11402667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.